ARK Investment Management LLC

13F Holdings History for 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG)

Symbol: TXG on Nasdaq
Investment type: Equity / Class A common stock, par value $0.00001 per share
Latest Disclosed Ownership: 11.9M shares
Security Ownership: 10.4%

Shares, Excluding Options vs Price

Value, Excluding Options

ARK Investment Management LLC ownership in 10x Genomics, Inc. Class A common stock, par value $0.00001 per share (TXG)

2025-11-04 - ARK Investment Management LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 11.9M shares of 10x Genomics, Inc. Class A common stock, par value $0.00001 per share (TXG). This represents 10.4% percent ownership of the company. In their previous filing dated 2025-05-14, ARK Investment Management LLC had reported owning 12.8M shares, indicating a decrease of -7.46% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
ARK Investment Management LLC	10.39%	-12.3%	$139M	11.9M	-958,317	-7.46%	$11.69	13G/A	9/30/2025	4 Nov 2025 16:43:50
ARK Investment Management LLC	11.87%		$98.9M	12.8M			$7.70	13G/A	3/31/2025	14 May 2025 10:50:17

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.83%	-0.14%	$139M	11.9M	-2,004,707	-14.4%	$11.69	Q3 2025
6/30/2025	1.18%	+0.09%	$161M	13.9M	+1,046,390	+8.15%	$11.58	Q2 2025
3/31/2025	1.12%	+0.08%	$112M	12.8M	+901,656		$8.73	Q1 2025
12/31/2024	1.43%	+0.14%	$172M	11.9M	+1,193,712	+11.1%	$14.36	Q4 2024
9/30/2024	2.22%	+0.3%	$243M	10.8M	+1,436,582	+15.4%	$22.58	Q3 2024
6/30/2024	1.61%	+0.41%	$181M	9.31M	+3,029,951	+48.2%	$19.45	Q2 2024
3/31/2024	1.63%	+0.5%	$236M	6.28M	+2,242,525	+55.5%	$37.53	Q1 2024
12/31/2023	1.34%	+0.45%	$226M	4.04M	+1,047,827	+35%	$55.96	Q4 2023
9/30/2023	0.94%	-0.04%	$123M	2.99M	-120,089	-3.86%	$41.25	Q3 2023
6/30/2023	1.15%	-0.39%	$174M	3.11M	-1,041,774	-25.1%	$55.84	Q2 2023
3/31/2023	1.59%	-0.06%	$232M	4.16M	-161,244	-3.74%	$55.79	Q1 2023
12/31/2022	1.36%	-0.08%	$157M	4.32M	-260,247	-5.69%	$36.44	Q4 2022
9/30/2022	0.92%	+0.2%	$130M	4.58M	+973,528	+27%	$28.48	Q3 2022
6/30/2022	1.09%	+0.06%	$184M	3.6M	+211,948	+6.25%	$51.19	Q2 2022
3/31/2022	1.08%	+0.23%	$258M	3.39M	+730,472	+27.5%	$76.07	Q1 2022
12/31/2021	1.2%	-0.2%	$396M	2.66M	-441,085	-14.2%	$148.96	Q4 2021
9/30/2021	1.08%	-0.32%	$452M	3.1M	-1,198,086	-27.9%	$145.58	Q3 2021
6/30/2021	1.57%	+0.31%	$842M	4.3M	+795,916	+22.7%	$195.82	Q2 2021
3/31/2021	1.26%	+1.43%	$634M	3.5M	+2,970,625	+557%	$181.00	Q1 2021
12/31/2020	0.2%	+0.11%	$75.5M	533K	+302,399	+131%	$141.60	Q4 2020
9/30/2020	0.17%	-0.08%	$28.8M	231K	-105,456	-31.3%	$124.68	Q3 2020
6/30/2020	0.32%	+0.32%	$30.1M	337K	+336,553	NEW	$89.31	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.